Renal denervation: intractable hypertension and beyond

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Nephrology

Background:

• Hypertension remains a significant public health issue, with some patients unresponsive to maximal medical and lifestyle interventions.
• Refractory hypertension poses a challenge, necessitating novel therapeutic approaches.
• Catheter-based renal denervation (RDN) has emerged as a promising new treatment avenue.

Purpose of the Study:

• To review the physiology and anatomy of the renal sympathetic nervous system.
• To discuss the renal denervation procedure, associated technologies, and clinical trial findings.
• To evaluate the safety and efficacy of RDN for refractory hypertension.

Main Methods:

• Literature review of renal sympathetic nervous system physiology and anatomy.
• Analysis of renal denervation procedures and technology systems.
• Examination of clinical trial data on RDN's antihypertensive effects, safety, and efficacy.

Main Results:

• Initial findings suggest that renal sympathetic denervation may offer therapeutic benefits for patients with refractory hypertension.
• The review covered renal nerve anatomy, RDN procedures, and technology.
• Antihypertensive effects, safety, and efficacy data were discussed.

Conclusions:

• Renal sympathetic denervation appears to be a potentially beneficial therapy for refractory hypertension.
• Limited clinical data are currently available, despite rapid advancements in RDN therapies.
• Further research, including robust randomized controlled trials, is essential to understand the long-term effects and consequences of RDN.